Overview

Thimerosal and Vaccine Policy in the United States: CDC Policy, Scientific Controversies, and the Future of Public Health Immunization Standards Thimerosal and Vaccine Policy in the United States offers a comprehensive examination of the critical issues shaping vaccination strategies today. This book outlines the removal of long-standing experts from the CDC's Advisory Committee on Immunization Practices (ACIP) and the appointment of new members under Health and Human Services Secretary Robert F. Kennedy Jr. It also investigates the renewed debate around thimerosal, a mercury-based preservative largely phased out decades ago, despite overwhelming scientific consensus on its safety. Thimerosal and Vaccine Policy in the United States addresses the scientific, ethical, and societal dimensions of vaccine policy, from the historical use of thimerosal to the latest advancements in RSV interventions. It provides an in-depth analysis of the Advisory Committee on Immunization Practices' evolving role, the impact of misinformation on public trust, and the imperative of equitable vaccine access. With a focus on evidence-based recommendations, this book equips policymakers, healthcare professionals, and concerned citizens with the knowledge to strengthen immunization programs and combat vaccine hesitancy. Discover actionable insights for fostering global collaboration, enhancing vaccine safety standards, and building resilient public health systems in an era of emerging infectious threats. ORDER A COPY NOW!!!

Full Product Details

9798290412849

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available